Answers are grounded in this paper and cite their sources.
An analysis of almost 400 cases of thrombo‐embolic disease in women on oral contraceptives, reported to the Swedish Adverse Drug Reaction Committee during the years (1965) 1966‐70, is presented. The risk of getting a thromboembolic manifestation may be calculated at 1: 3600 in users of oral contraceptives as compared with 1: 23000 among non‐users and 1: 340 during a normal pregnancy. The mortality risk is 0.9 patient per 100000 users and year. Details are presented for the 15 fatal cases. It is emphasized that although statistical evidence has demonstrated a significant relationship between the use of oral contraceptives and thromboembolic disease, in the individual case we have no way of telling what actually brought about the thromboembolic condition.
No takes yet. Share an insight, caveat, or question.
Böttiger et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: